Co-Diagnostics (CODX) Competitors $1.22 +0.01 (+0.83%) (As of 11/4/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends CODX vs. APYX, ICAD, PYPD, TELA, DRTS, LAKE, KRMD, TLSI, EDAP, and SRTSShould you be buying Co-Diagnostics stock or one of its competitors? The main competitors of Co-Diagnostics include Apyx Medical (APYX), iCAD (ICAD), PolyPid (PYPD), TELA Bio (TELA), Alpha Tau Medical (DRTS), Lakeland Industries (LAKE), KORU Medical Systems (KRMD), TriSalus Life Sciences (TLSI), Edap Tms (EDAP), and Sensus Healthcare (SRTS). These companies are all part of the "medical equipment" industry. Co-Diagnostics vs. Apyx Medical iCAD PolyPid TELA Bio Alpha Tau Medical Lakeland Industries KORU Medical Systems TriSalus Life Sciences Edap Tms Sensus Healthcare Apyx Medical (NASDAQ:APYX) and Co-Diagnostics (NASDAQ:CODX) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, media sentiment, analyst recommendations, profitability, risk, community ranking, dividends and earnings. Do analysts rate APYX or CODX? Apyx Medical currently has a consensus price target of $5.00, suggesting a potential upside of 331.03%. Co-Diagnostics has a consensus price target of $1.50, suggesting a potential upside of 22.95%. Given Apyx Medical's stronger consensus rating and higher possible upside, equities analysts clearly believe Apyx Medical is more favorable than Co-Diagnostics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Apyx Medical 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.75Co-Diagnostics 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Is APYX or CODX more profitable? Apyx Medical has a net margin of -57.86% compared to Co-Diagnostics' net margin of -411.18%. Co-Diagnostics' return on equity of -44.69% beat Apyx Medical's return on equity.Company Net Margins Return on Equity Return on Assets Apyx Medical-57.86% -105.45% -36.80% Co-Diagnostics -411.18%-44.69%-40.47% Which has more risk and volatility, APYX or CODX? Apyx Medical has a beta of 1.21, meaning that its stock price is 21% more volatile than the S&P 500. Comparatively, Co-Diagnostics has a beta of -0.84, meaning that its stock price is 184% less volatile than the S&P 500. Does the media refer more to APYX or CODX? In the previous week, Apyx Medical's average media sentiment score of 0.00 equaled Co-Diagnostics'average media sentiment score. Company Overall Sentiment Apyx Medical Neutral Co-Diagnostics Neutral Does the MarketBeat Community believe in APYX or CODX? Co-Diagnostics received 195 more outperform votes than Apyx Medical when rated by MarketBeat users. Likewise, 63.05% of users gave Co-Diagnostics an outperform vote while only 60.94% of users gave Apyx Medical an outperform vote. CompanyUnderperformOutperformApyx MedicalOutperform Votes7860.94% Underperform Votes5039.06% Co-DiagnosticsOutperform Votes27363.05% Underperform Votes16036.95% Do insiders & institutionals have more ownership in APYX or CODX? 55.3% of Apyx Medical shares are owned by institutional investors. Comparatively, 15.0% of Co-Diagnostics shares are owned by institutional investors. 16.8% of Apyx Medical shares are owned by company insiders. Comparatively, 6.1% of Co-Diagnostics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has stronger valuation and earnings, APYX or CODX? Apyx Medical has higher revenue and earnings than Co-Diagnostics. Apyx Medical is trading at a lower price-to-earnings ratio than Co-Diagnostics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioApyx Medical$52.35M0.77-$18.71M-$0.82-1.41Co-Diagnostics$6.81M5.72-$35.33M-$1.26-0.97 SummaryApyx Medical beats Co-Diagnostics on 12 of the 17 factors compared between the two stocks. Ad TradingTipsTop 10 AI Stocks to Buy NowAre you ready to capitalize on the booming AI market? Our experts have identified the top 10 AI stocks set to skyrocket.Download our free report today Get Co-Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for CODX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CODX vs. The Competition Export to ExcelMetricCo-DiagnosticsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$38.93M$4.18B$5.02B$8.40BDividend YieldN/A42.39%7.52%4.16%P/E Ratio-0.9739.98128.6416.67Price / Sales5.7252.111,718.2576.46Price / CashN/A49.1836.9133.53Price / Book0.434.424.595.18Net Income-$35.33M$11.11M$114.09M$223.67M7 Day Performance-2.40%-0.42%110.28%2.59%1 Month Performance-4.69%1.98%124.25%8.66%1 Year Performance-8.27%31.23%154.82%28.23% Co-Diagnostics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CODXCo-Diagnostics2.9945 of 5 stars$1.22+0.8%$1.50+23.0%-9.0%$38.93M$6.81M-0.97100Upcoming EarningsAPYXApyx Medical4.1502 of 5 stars$1.17-4.9%$5.00+327.4%-54.6%$42.61M$52.35M-1.43270Upcoming EarningsICADiCAD0.4906 of 5 stars$1.86+0.5%N/A+16.7%$49.10M$17.32M-16.9167Upcoming EarningsPYPDPolyPid2.2355 of 5 stars$3.20-9.6%$14.00+337.5%-14.9%$16.98MN/A-0.3280Analyst ForecastGap UpTELATELA Bio3.0405 of 5 stars$2.81-1.1%$10.00+255.9%-50.2%$70.19M$58.45M-1.63120Upcoming EarningsGap UpDRTSAlpha Tau Medical1.8371 of 5 stars$2.34+5.4%$8.00+241.9%-28.1%$154.67MN/A-5.8580Gap DownLAKELakeland Industries4.8627 of 5 stars$18.59-4.4%$26.50+42.5%+31.4%$143.79M$124.69M77.461,750Gap DownHigh Trading VolumeKRMDKORU Medical Systems1.3373 of 5 stars$2.92+11.0%$3.33+14.2%+21.1%$120.60M$28.52M-11.6880Negative NewsTLSITriSalus Life Sciences3.3203 of 5 stars$3.97-0.3%$12.50+214.9%-7.0%$116.66M$18.51M-1.59106Gap DownHigh Trading VolumeEDAPEdap Tms2.2368 of 5 stars$2.90-3.0%$14.00+382.8%-59.7%$110.94M$65.42M-5.00307Upcoming EarningsSRTSSensus Healthcare3.1992 of 5 stars$6.40-5.2%$10.00+56.3%+198.6%$110.63M$24.41M15.6140Positive News Related Companies and Tools Related Companies APYX Competitors ICAD Competitors PYPD Competitors TELA Competitors DRTS Competitors LAKE Competitors KRMD Competitors TLSI Competitors EDAP Competitors SRTS Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CODX) was last updated on 11/4/2024 by MarketBeat.com Staff From Our Partners2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredA Totally New ‘Income Coin’Buckle up… Because this might shatter everything you thought you knew about "income trading." In fact, i...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Co-Diagnostics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Co-Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
